Knight Therapeutics Stock
Price
Target price
€3.88
€3.88
-1.520%
-0.06
-1.520%
-
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Knight Therapeutics Stock
We can see a decrease in the price for Knight Therapeutics. Compared to yesterday it has lost -€0.060 (-1.520%).
Pros and Cons of Knight Therapeutics in the next few years
Pros
?
C******** o* t** e**********
?
W********* I********* f** t** n*** y****
?
B****
Cons
?
S********** s********
?
M***** P*******
?
G***** c******* t* c**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Knight Therapeutics vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Knight Therapeutics | -1.520% | -1.020% | 6.593% | -0.513% | 4.301% | 13.450% | 13.450% |
| Biomark Diagnostics Inc. | 0.000% | 2.198% | 21.569% | 175.556% | 34.783% | 247.664% | 33.813% |
| MicroPlanet Technology Corp | 1.720% | 0.855% | -11.940% | 46.766% | -22.368% | -14.493% | -42.157% |
| Avricore Health Inc. | 5.190% | 5.195% | 19.118% | 72.340% | 76.087% | -78.906% | -81.757% |
News
EVP of North America's Largest Full Truckload Company EVP Sells All Insider Shares
Michael K Liu, EVP - Operations at Knight-Swift (NYSE:KNX), disposed of 1,243 directly held shares in an open-market sale on Feb. 4, 2026, fully exiting his direct equity position according to a SEC
Changing Your Dog's Diet May Help the Planet More Than Changing Your Own, Study Finds
LONDON, UK / ACCESS Newswire / February 10, 2026 / Diets high in meat, eggs, and dairy products incur significant environmental costs. But a new study has revealed that, in many cases,
One Fund Just Sold $23 Million of This Major Freight Stock. Here's What Investors Should Know
On February 4, Triton Wealth Management, PLLC reported selling 481,779 shares of Knight-Swift Transportation Holdings (NYSE:KNX), an estimated $22.58 million trade based on quarterly average